Clinical Trials Browser

Recruiting × Rectal Neoplasms × regorafenib × Clear all

NCT06911684 2025-04-23

Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT04503694 2025-03-05

REGINA

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms